Chemoinformaics analysis of 1-Propanamine (CAS) n-Propylamine
Molecular Weight | 89.138 | nRot | 3 |
Heavy Atom Molecular Weight | 78.05 | nRig | 0 |
Exact Molecular Weight | 89.0841 | nRing | 0 |
Solubility: LogS | 1.134 | nHRing | 0 |
Solubility: LogP | -0.56 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 15.9167 |
nHD | 1 | BPOL | 12.2013 |
QED | 0.493 |
Synth | 1.938 |
Natural Product Likeliness | 0.314 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.027 |
HIA | 0.011 |
CACO-2 | -5.011 |
MDCK | 0.000518088 |
BBB | 0.348 |
PPB | 0.0595949 |
VDSS | 1.06 |
FU | 0.903987 |
CYP1A2-inh | 0.028 |
CYP1A2-sub | 0.532 |
CYP2c19-inh | 0.02 |
CYP2c19-sub | 0.707 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.147 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.59 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.259 |
CL | 6.219 |
T12 | 0.508 |
hERG | 0.036 |
Ames | 0.067 |
ROA | 0.573 |
SkinSen | 0.715 |
Carcinogencity | 0.496 |
EI | 0.411 |
Respiratory | 0.89 |
NR-Aromatase | 0.009 |
Antiviral | No |
Prediction | 0.958947 |